Evidence map›Paper›PMID 42195511›Full record

ArticleMicromachines2026

Fabrication and Characterization of Zein/Sodium Alginate Nanoparticles Loaded with Oxyresveratrol: Formation Mechanism, Molecular Dynamics Insights, and In Vitro Antioxidant Capacity.

Xiaomin Luo, Zhiyun Du

Abstract read
In one paragraph

Article in Micromachines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xiaomin LuoSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China.
Zhiyun DuSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China.

Funding

Guangdong Basic and Applied Basic Research foundation 2024A1515010863Guangdong Special Support Program for Young Top-notch Talent Cultivation Project 2024TQ08X736Guangdong S&T Program 2024B0101120003National Key R&D Program of China 2024YFE0205600
6 · The paper itself

Abstract

Oxyresveratrol (Oxy) exhibits a diverse range of biological activities. However, its practical application is constrained by low aqueous solubility and chemical instability. In this work, Oxy-loaded zein (Z) nanoparticles (NPs) stabilized by a sodium alginate (Alg) coating (Oxy-Z/Alg NPs) were fabricated using an antisolvent precipitation method. The absence of crystalline peaks in X-ray diffraction analysis suggested that Oxy was dispersed as an amorphous phase in NPs, while the Fourier transform infrared spectra identified strong interfacial associations between the components. The stabilization of the NPs is attributed to the site-specific binding of Oxy with Z's SER-162 and GLN-174 residues. Molecular docking, molecular dynamics simulations, and differential scanning calorimetry profiles evidenced the formation of intermolecular hydrogen bonds. Dynamic light scattering analysis showed that the nanocomplexes had a nano-scale dimension (243 ± 6 nm) and a zeta potential of -36 mV. SEM micrographs revealed that the NPs possessed a spherical morphology. The NPs exhibited colloidal stability against prolonged heating (80 °C for 75 min), ionic strengths (up to 100 mM NaCl), and pH range (2.0-10.0). Encapsulation within the Alg coating enhanced Oxy's antioxidant capacity over its unprotected form by shielding its core bioactivity from degradation. The Oxy-Z/Alg nano-system shows significant promise for the encapsulation of Oxy, providing a practical basis for its integration into nutraceuticals and functional food fields.

Indexed as

molecular dynamicsnanotechnologyOxyresveratrolself-assemblyzein

Identifiers

PMID42195511
PMCPMC13208874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.